Auriga Reiteratess a 'Hold' on Laboratory Corporation (LH); Expect In-line to Slightly Better 4Q Results
LH Hot Sheet
Rating Summary:6 Buy, 10 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 82
Auriga reiteratess a 'Hold' on Laboratory Corporation of America (NYSE: LH) price target of $91.00.
Auriga analyst says, "Based on recent results by LH’s largest peer Quest Diagnostics (NYSE: DGX)(Hold Rated) there is a strong possibility that LH may beat our/consensus revenue/EPS estimates for 4Q mainly on improving volume trends. Furthermore, DGX indicated on its call that physician office visits appear to have stabilized, but stopped short from calling it an uptrend. This is a positive data point, which we take into consideration when modeling our 2012 results. That being said, until we confirm a “true” uptrend in lab test volumes we are not willing to assign multiple higher than 13x to derive our price target."
For an analyst ratings summary and ratings history on Laboratory Corporation of America click here. For more ratings news on Laboratory Corporation of America click here.
Shares of Laboratory Corporation of America closed at $91.99 yesterday, with a 52 week range of $74.57-$100.94.
Discover Wall Street's best ratings calls with the pros - Ratings Insider Elite. Free Trial!
Auriga analyst says, "Based on recent results by LH’s largest peer Quest Diagnostics (NYSE: DGX)(Hold Rated) there is a strong possibility that LH may beat our/consensus revenue/EPS estimates for 4Q mainly on improving volume trends. Furthermore, DGX indicated on its call that physician office visits appear to have stabilized, but stopped short from calling it an uptrend. This is a positive data point, which we take into consideration when modeling our 2012 results. That being said, until we confirm a “true” uptrend in lab test volumes we are not willing to assign multiple higher than 13x to derive our price target."
For an analyst ratings summary and ratings history on Laboratory Corporation of America click here. For more ratings news on Laboratory Corporation of America click here.
Shares of Laboratory Corporation of America closed at $91.99 yesterday, with a 52 week range of $74.57-$100.94.
Discover Wall Street's best ratings calls with the pros - Ratings Insider Elite. Free Trial!
You May Also Be Interested In
- Barclays Maintains an 'Equalweight' on Apollo Commercial Real Estate Finance (ARI); Effectively Using Capital, But Shares Trading In-line Vs. Peers
- Canaccord Genuity maintains a 'Buy' on Auxilium Pharmaceuticals (AUXL); Bumping Guidance on Testim Partnership with GSK
- Oppenheimer Reiterates an 'Outperform' on MakeMyTrip (MMYT); Updating Estimates Ahead of March Qtr
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS ViewRelated Entities
AurigaSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
